Kaizen Bio-Tech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Kaizen Bio-Tech General Information

Description

Developer of a disposable measuring device designed to measure the amount of breastfeeding. The company's device helps nursing mothers to gain a reliable indication of the amount of milk their baby is receiving, enabling mothers and health professionals to accurately and naturally measure milk output.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Haeshel 5
  • Keisarya 3079815
  • Israel
+972
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Haeshel 5
  • Keisarya 3079815
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaizen Bio-Tech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Startup
2. Later Stage VC 03-Jan-2022 Completed Startup
1. Later Stage VC 01-Feb-2017 $1M $1M Completed Startup
To view Kaizen Bio-Tech’s complete valuation and funding history, request access »

Kaizen Bio-Tech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A2
Preferred A1
To view Kaizen Bio-Tech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kaizen Bio-Tech Patents

Kaizen Bio-Tech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026159704-A1 Nipple shield device, system and method to detect a milk flow rate from a mother's breast Pending 21-Jan-2025
US-D1058823-S1 Nipple shield Active 27-Aug-2024
EP-4734908-A1 Nipple cleaning kit Pending 27-Jun-2023
AU-2023250451-A1 System for electronic measurement of milk imbibed by an infant Pending 03-Apr-2022
EP-4504123-A2 System for electronic measurement of milk imbibed by an infant Pending 03-Apr-2022 G01F1/36
To view Kaizen Bio-Tech’s complete patent history, request access »

Kaizen Bio-Tech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Capital Resources Inc Corporation Minority
Angel (individual) Minority
Angel (individual) Minority
To view Kaizen Bio-Tech’s complete investors history, request access »

Kaizen Bio-Tech FAQs

  • When was Kaizen Bio-Tech founded?

    Kaizen Bio-Tech was founded in 2011.

  • Where is Kaizen Bio-Tech headquartered?

    Kaizen Bio-Tech is headquartered in Keisarya, Israel.

  • What industry is Kaizen Bio-Tech in?

    Kaizen Bio-Tech’s primary industry is Monitoring Equipment.

  • Is Kaizen Bio-Tech a private or public company?

    Kaizen Bio-Tech is a Private company.

  • What is Kaizen Bio-Tech’s current revenue?

    The current revenue for Kaizen Bio-Tech is .

  • How much funding has Kaizen Bio-Tech raised over time?

    Kaizen Bio-Tech has raised $3.85M.

  • Who are Kaizen Bio-Tech’s investors?

    , Capital Resources Inc, , and have invested in Kaizen Bio-Tech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process